Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer-Reference-Cited by-同舟云学术

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

Published:2016-06-29 Issue:7 Volume:5 Page:e1149667
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Millen Rosemary,Malaterre Jordane,Cross Ryan S.,Carpinteri Sandra,Desai Jayesh,Tran Ben,Darcy Phillip,Gibbs Peter,Sieber Oliver,Zeps Nikolajs,Waring Paul,Fox Stephen,Pereira Lloyd,Ramsay Robert G.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2016.1149667

Reference36 articles.

1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

2. The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective: Figure 1.

3. Immune classification of colorectal cancer patients: impressive but how complete?

4. Colorectal cancer mouse models: Integrating inflammation and the stroma

5. Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of MYB transcription factors in cancer drug resistance;Cancer Drug Resistance;2024-04-30

2. From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies;Cancer and Metastasis Reviews;2023-11-10

3. Tumor Cell–Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model;Cancer Immunology Research;2023-09-07

4. Immunotherapies catering to the unmet medical need of cold colorectal cancer;Frontiers in Immunology;2022-10-05

5. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC;Clinical Immunology;2022-04